5 suspended. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Suspended 5 |
Follow Autoimmune Diseases: new trials by email Literature Review of Autoimmune Diseases trials Research Report on Autoimmune Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis IDP-023, Ocrelizumab, Interleukin-2 - Multiple Sclerosis, Primary Progressive Multiple Sclerosis (PPMS) | Phase 1 | Suspended | Indapta Therapeutics, INC. | 34 | 2026-06-30 | 2025-04-30 |
| A First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK4347859 in Healthy Participants GSK4347859, Placebo - Systemic Lupus Erythematosus | Phase 1 | Suspended | GlaxoSmithKline | 65 | 2024-01-12 | 2025-10-03 |
| Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes. [Zr-89]Oxine-labeled leukocytes PET/MRI - Fibromyalgia, Chronic Fatigue Syndrome | Phase 1 | Suspended | University of Alabama at Birmingham | 120 | 2021-10-05 | 2026-06-02 |
| Zr-89 Cimzia PET Imaging Rheumatoid Arthritis 89Zr-DFO-CZP - Rheumatoid Arthritis | Phase 1 | Suspended | Robert Flavell, MD, PhD | 10 | 2018-10-01 | 2026-05-04 |
| Islet Allotransplantation in Type 1 Diabetes Human Pancreatic Islets - Type 1 Diabetes | Phase 1 | Suspended | Ohio State University | 20 | 2006-11-01 | 2025-01-16 |
Multiple Sclerosis (2) · Arthritis, Rheumatoid (1) · Autoimmune Diseases of the Nervous System (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Diabetes Mellitus, Type 1 (1) · Fatigue Syndrome, Chronic (1) · Fibromyalgia (1) · Immune System Diseases (1) · Lupus Erythematosus, Systemic (1) · Multiple Sclerosis, Chronic Progressive (1) · Nervous System Diseases (1)
Immune System Diseases (4) · Chronic Disease (2) · Connective Tissue Diseases (2) · Disease Attributes (2) · Musculoskeletal Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Rheumatic Diseases (2) · Skin and Connective Tissue Diseases (2) · Arthritis (1) · Autoimmune Diseases of the Nervous System (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Demyelinating Autoimmune Diseases, CNS (1)
Cyclophosphamide (1) · Interleukin-2 (1) · Mesna (1) · aldesleukin (1) · fludarabine (1) · ocrelizumab (1)
GlaxoSmithKline (1) · Indapta Therapeutics, INC. (1) · Ohio State University (1) · Robert Flavell, MD, PhD (1) · University of Alabama at Birmingham (1)
United States (4) · United Kingdom (1)
Amer Rajab, MD, PhD (1) · Jonathan McConathy, MD,PhD (1) · Robert Flavell, MD, PhD (1)